Financiën Merck & Co., Inc.

Aandelen

MRK

US58933Y1055

Farmaceutische producten

Beurs gesloten - Nyse Andere beurzen 22:00:02 16-01-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
108,83 ^USD	-1,93%		-1,54%	+3,39%

16/01	Sommige farmabedrijven uiten stille bezorgdheid over juridische risico's bij versnelde FDA-beoordelingsprogramma	RE
15/01	Farmasector verdubbelt inzet op AI in de hoop kosten en doorlooptijden drastisch te verlagen	RE

Voorlopige winst- en verliesrekening: Merck & Co., Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Omzet ¹	47.994	48.704	59.283	60.115	64.168	64.786	67.958	71.488
Variatie	-	1,48%	21,72%	1,4%	6,74%	0,96%	4,9%	5,19%
EBITDA ¹	20.570	20.910	26.431	10.083	27.897	30.126	24.900	33.765
Variatie	-	1,65%	26,4%	-61,85%	176,67%	7,99%	-17,35%	35,6%
Bedrijfsresultaat (EBIT) ¹	16.945	17.696	22.522	6.211	23.398	26.769	21.372	30.513
Variatie	-	4,43%	27,27%	-72,42%	276,72%	14,41%	-20,16%	42,77%
Betaalde rente ¹	-772	-770	-805	-781	-856	-804	-822,5	-317
Resultaat voor belastingen (EBT) ¹	8.791	13.879	16.444	1.889	19.936	22.622	16.778	30.130
Variatie	-	57,88%	18,48%	-88,51%	955,37%	13,47%	-25,83%	79,58%
Nettowinst (verlies) ¹	7.067	13.049	14.519	365	17.117	20.098	16.050	24.029
Variatie	-	84,65%	11,27%	-97,49%	4.589,59%	17,42%	-20,14%	49,71%
Datum van publicatie	4/02/21	3/02/22	2/02/23	1/02/24	4/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: december	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Omzet ¹	12.514	12.080	11.402	13.154	13.521	15.901	14.593	14.959	13.830	14.487	15.035	15.962	14.630	15.775	16.112	16.657	15.624	15.529	15.806	17.276	16.192	15.991	16.606	17.884	17.136
Variatie	-	-3,47%	-5,61%	15,37%	2,79%	17,6%	-8,23%	2,51%	-7,55%	4,75%	3,78%	6,17%	-8,34%	7,83%	2,14%	3,38%	-6,2%	-0,61%	1,78%	9,3%	-6,27%	-1,24%	3,85%	7,69%	-4,18%
EBITDA ¹	4.608	5.220	4.659	6.111	5.670	7.568	6.649	6.516	5.698	5.402	-3.485	7.538	665	7.367	7.177	5.466	6.422	7.722	7.484	8.710	8.014	2.996	7.795	9.213	-
Variatie	-	13,28%	-10,75%	31,17%	-7,22%	33,47%	-12,14%	-2%	-12,55%	-5,19%	-164,51%	316,3%	-91,18%	1.007,82%	-2,58%	-23,84%	17,49%	20,24%	-3,08%	16,38%	-7,99%	-62,61%	160,16%	18,19%	-
Bedrijfsresultaat (EBIT) ¹	3.704	4.290	3.969	5.352	4.835	6.448	5.711	5.557	4.806	4.411	-4.388	6.524	-299	6.383	6.659	4.913	5.225	6.623	6.365	7.556	6.200	1.975	6.725	7.946	6.241
Variatie	-	15,82%	-7,48%	34,85%	-9,66%	33,36%	-11,43%	-2,7%	-13,51%	-8,22%	-199,48%	248,68%	-104,58%	2.234,78%	4,32%	-26,22%	6,35%	26,76%	-3,9%	18,71%	-17,95%	-68,15%	240,55%	18,15%	-21,46%
Charge d'intérêts ¹	-196	-	-202	-189	-200	-236	-225	-204	-140	-130	-168	-244	-240	-230	-241	-203	-182	-204	-236	-231	-320	-	-	-	-
Resultaat voor belastingen (EBT) ¹	-	-	1.717	-	-	-	-	3.583	3.513	3.650	-5.335	5.620	-2.046	5.670	6.006	4.090	4.170	5.903	4.999	6.745	4.438	-	-	-	-
Variatie	-	-	-	-	-	-	-	-	-1,95%	3,9%	-246,16%	205,34%	-136,41%	377,13%	5,93%	-31,9%	1,96%	41,56%	-15,31%	34,93%	-34,2%	-	-	-	-
Nettowinst (verlies) ¹	-2.094	3.179	1.214	4.567	3.758	4.310	3.944	3.248	3.017	2.821	-5.975	4.745	-1.226	4.762	5.455	3.157	3.743	5.079	4.427	5.785	4.274	-1.883	5.924	6.976	-
Variatie	-	251,81%	-61,81%	276,19%	-17,71%	14,69%	-8,49%	-17,65%	-7,11%	-6,5%	-311,8%	179,41%	-125,84%	488,42%	14,55%	-42,13%	18,56%	35,69%	-12,84%	30,68%	-26,11%	-144,06%	414,55%	17,75%	-
Datum van publicatie	4/02/21	29/04/21	29/07/21	28/10/21	3/02/22	28/04/22	28/07/22	27/10/22	2/02/23	27/04/23	1/08/23	26/10/23	1/02/24	25/04/24	30/07/24	31/10/24	4/02/25	24/04/25	29/07/25	30/10/25	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Merck & Co., Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Nettoschuld ¹	23.729	25.006	17.499	27.962	23.869	26.265	18.546	2.235
Variatie	-	5,38%	-30,02%	59,79%	-14,64%	10,04%	-29,39%	-87,95%
Datum van publicatie	4/02/21	3/02/22	2/02/23	1/02/24	4/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Merck & Co., Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	4.684	4.448	4.388	3.863	3.372	3.111	3.213	3.326
Variatie	-	-5,04%	-1,35%	-11,96%	-12,71%	-7,73%	3,28%	3,51%
Vrije kasstroom (FCF) ¹	5.569	8.674	14.707	9.143	18.096	25.211	20.041	25.120
Variatie	-	55,76%	69,55%	-37,83%	97,92%	39,32%	-20,51%	25,34%
Datum van publicatie	4/02/21	3/02/22	2/02/23	1/02/24	4/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Merck & Co., Inc.

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Winstgevendheid
EBITDA-marge (%)	42,86%	42,93%	44,58%	16,77%	43,47%	46,5%	36,68%	47,28%
EBIT-marge (%)	35,31%	36,33%	37,99%	10,33%	36,46%	41,33%	31,37%	42,56%
EBT-marge (%)	18,32%	28,5%	27,74%	3,14%	31,07%	34,92%	24,71%	42,19%
Nettomarge (%)	14,72%	26,79%	24,49%	0,61%	26,68%	31,04%	23,42%	33,17%
FCF-marge (%)	11,6%	17,81%	24,81%	15,21%	28,2%	38,91%	29,52%	35,18%
Vrije kasstroom/nettoresultaat (%)	78,8%	66,47%	101,29%	2.504,93%	105,72%	125,37%	126,03%	106,04%
Winstgevendheid
ROA	17,14%	13,23%	17,69%	3,56%	17,38%	16,7%	10,03%	17,84%
ROE	58,89%	41,1%	45,16%	9,18%	46,35%	44,64%	27,9%	41,24%
Financiële gezondheid
Hefboom (schuld/ebitda)	1,15x	1,2x	0,66x	2,77x	0,86x	0,87x	0,74x	0,07x
Schuld/vrije kasstroom	4,26x	2,88x	1,19x	3,06x	1,32x	1,04x	0,93x	0,09x
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	9,76%	9,13%	7,4%	6,43%	5,25%	4,8%	4,73%	4,66%
CAPEX / EBITDA (%)	22,77%	21,27%	16,6%	38,31%	12,09%	10,33%	12,9%	9,85%
CAPEX / FCF (%)	84,11%	51,28%	29,84%	42,25%	18,63%	12,34%	16,03%	13,24%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	4,035	5,17	7,512	5,106	8,449	9,879	7,218	12,2
Variatie	-	28,13%	45,29%	-32,02%	65,45%	16,93%	-26,93%	69,05%
Dividend per aandeel ¹	2,48	2,64	2,8	2,96	3,12	3,234	3,282	3,529
Variatie	-	6,45%	6,06%	5,71%	5,41%	3,66%	1,49%	7,51%
Nettoactief per aandeel ¹	10,01	15,11	18,12	14,84	18,29	21,73	24,69	30,62
Variatie	-	50,98%	19,96%	-18,09%	23,22%	18,8%	13,62%	24,03%
WPA ¹	2,78	5,14	5,71	0,14	6,74	7,812	6,292	9,626
Variatie	-	84,89%	11,09%	-97,55%	4.714,29%	15,9%	-19,45%	52,97%
Aantal aandelen (in duizend)	2.530.034	2.525.944	2.535.396	2.534.023	2.529.636	2.482.023	2.482.023	2.482.023
Datum van publicatie	4/02/21	3/02/22	2/02/23	1/02/24	4/02/25	-	-	-